CD44 and neoplasm: (E) Kaplan–Meier analysis of the DFS in the testing group of TNBC patients with chemotherapy after they were stratified into ≥19.5% of CD44-/CD24- (n = 24) vs. <19.5% of CD44-/CD24- tumor cells (n = 35).